Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
73.3M
-
Number of holders
-
193
-
Total 13F shares, excl. options
-
76.5M
-
Shares change
-
+1.1M
-
Total reported value, excl. options
-
$1.47B
-
Value change
-
-$15.2M
-
Put/Call ratio
-
0.23
-
Number of buys
-
98
-
Number of sells
-
-85
-
Price
-
$19.17
Significant Holders of ARVINAS, INC. - Common Stock (ARVN) as of Q4 2024
246 filings reported holding ARVN - ARVINAS, INC. - Common Stock as of Q4 2024.
ARVINAS, INC. - Common Stock (ARVN) has 193 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 76.5M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (7.06M shares), EcoR1 Capital, LLC (6.73M shares), BlackRock, Inc. (6.57M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.1M shares), Pfizer Inc (3.46M shares), RTW INVESTMENTS, LP (3.33M shares), CITADEL ADVISORS LLC (3.07M shares), Bellevue Group AG (2.39M shares), T. Rowe Price Investment Management, Inc. (2.21M shares), and UBS Group AG (2.04M shares).
This table shows the top 193 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.